|
MedChemExpress (MCE) 提供多元的高品質研究化學品和生物化學品,包括用於實驗室和科學用途的新型生物活性化合物、染劑、胜肽和天然化合物。
|
• 超過 50,000 種生物活性分子化合物的庫存
|
|
• 超過針對20多種訊號傳遞路徑中的500多種關鍵目標蛋白的化合物
|
• 產品均附上品質報告書(LC/MS、NMR 和 HPLC)
|
• 每月發佈超過1000 種最新的產品
|
• 提供詳細Datasheet的資訊
|
|
• 高純度和有競爭力的價格
|
|
• 快速到貨
|
|
|
CAS No.: 2488952-40-3
|
|
|
Research Area: EED Inhibitor/Lymphoma
|
|
•
|
A potent and orally active embryonic ectoderm development (EED) inhibitor with an IC50 of 0.2 nM.
|
•
|
Efficaciously inhibits Pfeiffer and KARPAS422 lymphoma cancer cells with IC50 values of 20 pM and 0.5 nM, respectively.
|
•
|
Significantly induces tumor regression in KARPAS422 xenograft mouse models.
|
|
|
Solubility: DMSO : 125 mg/mL (260.67 mM; Need ultrasonic)
|
|
|
CAS No.: 859525-02-3
|
|
|
Research Area: Glucokinase Activator/Type 1 and 2 Diabetes
|
|
•
|
An orally active and liver-selective glucokinase (GK) activator.
|
•
|
Increases glucose metabolism in rat hepatocytes with EC50 values of 2.39 μM and 2.64 μM for lactate and glycogen, respectively.
|
•
|
Reduces blood glucose, lactate and triglyceride concentrations in ob/ob mouse models with severe diabetes.
|
|
|
Solubility: DMSO : 125 mg/mL (274.35 mM; Need ultrasonic)
|
|
|
CAS No.: 371217-32-2
|
|
|
Research Area: ASIC-3 Inhibitor/Depression and Pain
|
|
•
|
A potent acid-sensing ion channel 3 (ASIC-3) inhibitor with an IC50 of 1.025 μM.
|
•
|
Dose-dependently inhibits all ASIC currents (IC50s of 2-30 µM).
|
•
|
Shows fully analgesic effects in Complete Freund’s adjuvant (CFA)-induced inflammatory thermal hyperalgesia rat models.
|
|
|
Solubility: DMSO : 125 mg/mL (314.42 mM; Need ultrasonic)
|
|
|
CAS No.: 2758364-02-0
|
|
|
Research Area: BRCA2-RAD51 Interaction Inhibitor/Cancer
|
|
•
|
A selective orthosteric inhibitor of BRCA2-RAD51 interaction with a Kd of 366 nM.
|
•
|
Dose-dependently decreases RAD51 nuclear foci and inhibits DNA repair.
|
•
|
Induces cell-cycle arrest and cell apoptosis.
|
|
|
Solubility: DMSO : 125 mg/mL (236.31 mM; Need ultrasonic)
|
|
|
CAS No.: 1375752-78-5
|
|
|
|
Research Area: mGluR5 Silent Allosteric Modulator/Alzheimer’s Disease
|
|
•
|
An orally active and BBB penetrable mGluR5 silent allosteric modulator (SAM) with a Ki value of 0.6 nM.
|
•
|
Prevents amyloid-β oligomer (Aβo) mediated toxicity and Aβo-induced signal transduction in brain slices.
|
•
|
Rescues memory deficits and synaptic depletion in Alzheimer’s disease transgenic mouse models.
|
|
|
Solubility: DMSO : 100 mg/mL (266.79 mM; Need ultrasonic)
|
|
|
MCE分子膠化合物庫
|
|
|
靶向蛋白質降解Targeted protein degradation(TPD)是一種新型且有潛力的新藥發現和開發方法,其顯示出治療具有“非藥性”致病蛋白靶標的疾病和克服抗藥性的巨大潛力。分子膠和PROTACs都是最受關注的靶向蛋白降解劑。
分子膠是小分子降解劑,主要誘導 E3 ligase與靶蛋白之間的相互作用並形成復合物,進而導致蛋白質泛素化和隨後的蛋白酶體降解。與 PROTAC 相比,分子膠通常具有更有利的類藥物特性,如: 更低的分子量、更高的細胞滲透性和更好的吸收,分子膠正在成為一種有前途的新治療策略。
MCE 提供獨特的 30 多種針對各種蛋白質的分子膠,MCE分子膠化合物庫是進行科學研究和疾病機制研究的最強工具。 |
|
|
|
|
|
|
最新文獻引用MCE產品
|
|
Nature.
2022 Dec;612(7940):555-563.
|
|
|
Science.
2022 Dec 2;378(6623):eabo5503.
|
|
|
Cell.
2022 Nov 10;185(23):4347-4360.e17.
|
|
|
Cell.
2022 Dec 8;185(25):4801-4810.e13.
|
|
|
|
|
|
|
|
|
|
|